Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

RNA-directed gene therapy targeting shPromA/shCCR5 tested in chronic HIV infection model

July 23, 2021

XPB shown to regulate HIV-1 transcriptional activity

July 22, 2021

IRF7 and PTDSS2 are therapeutic targets in HIV-1 infection

July 22, 2021

Studies show NNRTI MK-8507 can be used with islatravir, levonorgestrel/ethinyl estradiol

July 22, 2021

All together now: Cure research plays big role at IAS 2021

July 21, 2021

Rab35-silencing as new strategy to impair HIV propagation

July 21, 2021

Lenacapavir confers viral suppression by week 16 in HIV-infected patients

July 20, 2021

Modulation of STAT pathway with HODHBt improves NK cell cytotoxicity

July 20, 2021

GS-9822 retargets integration sites and induces deep latent state in vitro

July 20, 2021

ViiV initiates phase II study of GSK-3810109A in antiretroviral-naive HIV-1-infected adults

July 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...